Search - tctmd.com

Displaying 161 - 180 of 465

Sort: Relevancy | Date

News Conference News ESC 2020

Go With Aspirin Alone After TAVR When Anticoagulation Isn’t Needed: POPular TAVI

Todd Neale

August 30, 2020

News Daily News

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

L.A. McKeown

August 17, 2020

News Daily News

Next-Day Discharge Safe After Uncomplicated Transfemoral TAVR

Todd Neale

August 12, 2020

News Daily News

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

L.A. McKeown

July 17, 2020

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

Presentation TVT 2020

First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation

Presenter: Hasan Jilaihawi

June 21, 2020

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

News Conference News ACC 2020

UK TAVI: Real-world TAVR and SAVR Have Similar 1-Year Mortality

L.A. McKeown

March 29, 2020

News Daily News

Meta-analysis Reassures on Benefits of TAVR in Cancer Patients

L.A. McKeown

March 16, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

News Conference News CRT 2020

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

L.A. McKeown

February 24, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

News Conference News STS 2020

For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns

Yael L. Maxwell

January 30, 2020

News Conference News STS 2020

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

Yael L. Maxwell

January 29, 2020

Advertisement

Go With Aspirin Alone After TAVR When Anticoagulation Isn’t Needed: POPular TAVI

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

Next-Day Discharge Safe After Uncomplicated Transfemoral TAVR

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

UK TAVI: Real-world TAVR and SAVR Have Similar 1-Year Mortality

Meta-analysis Reassures on Benefits of TAVR in Cancer Patients

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content